5-SENSE Score Validation Study | MicrobiomeTrials← Back to trialsNCT06138808
5-SENSE Score Validation Study
ENROLLING_BY_INVITATIONOBSERVATIONAL
Trial Details
Start: 2024-01-09Est. Completion: 2027-01
Enrollment target: 400 participants Locations- University of Florida College of Medicine, Gainesville, Florida, United States
- Northwestern University, Chicago, Illinois, United States
- Duke University Health System, Durham, North Carolina, United States
- Presbyterian-Shadyside Hospital, Pittsburgh, Pennsylvania, United States
- Monash University, Melbourne, Victoria, Australia
- Mater Health, Brisbane, Australia
- Alfred Health, Melbourne, Australia
- Christian Doppler University Hospital Paracelsus Medical University Salzburg and Centre for Cognitive Neuroscience Salzburg, Salzburg, Austria
- Dalhousie Universiry and Hospital, Dalhousie, Nova Scotia, Canada
- Wester University, London, Ontario, Canada
- Departmet of Neurology, Masaryk University Brno, Brno, Czechia
- Danish Epilepsy Centre, Aarhus Universitets Hospital, Aarhus, Denmark
- Grenoble Institute of Neurosciences, Centre Hospitalier Universitaire Grenoble Alpes, Grenoble, France
- Epilepsy Department University Hospitals of Marseille, Marseille, France
- Epilepsy Centre, University Hospital Freiburg, Freiburg im Breisgau, Germany
- University School of Medicine Kyoto, Kyoto, Japan
- "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania
- Hospital Universitario y Politecnico La Fe, Valencia, Spain
- Department of Clinical Neurosciences chez CHUV; Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
Other microbiome trials you might be interested in
Drug Resistant Epilepsy
The purpose of this study is to assess the safety and performance of the iVEAcare Neuromodulation System for the treatme…
Multiple LocationsEst. completion Jun 2027
EpilepsyIdiopathic Generalized EpilepsyGeneralized Tonic Clonic Seizure
To demonstrate that the RNS System for thalamic stimulation is safe and effective as an adjunctive therapy for the reduc…
Birmingham, United StatesCompleted Apr 4, 2025
Phase 1
Recruiting
Background:
\- The blood-brain barrier separates the brain from the rest of the body. Epilepsy is a neurological diseas…
Bethesda, United StatesEst. completion Jul 1, 2030